share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144：拟议出售证券

SEC announcement ·  03/04 17:45
Moomoo AI 已提取核心信息
Arcutis Biotherapeutics, Inc. officer Matsuda Masaru is set to sell 3,760 shares of common stock on March 4, 2024, with an aggregate market value of $41,815. The shares were acquired on March 1, 2024, through a restricted stock vest from Arcutis Biotherapeutics. This transaction follows a period where no previous sales were reported in the past three months.
Arcutis Biotherapeutics, Inc. officer Matsuda Masaru is set to sell 3,760 shares of common stock on March 4, 2024, with an aggregate market value of $41,815. The shares were acquired on March 1, 2024, through a restricted stock vest from Arcutis Biotherapeutics. This transaction follows a period where no previous sales were reported in the past three months.
Arcutis Biotherapeutics, Inc.高管松田正定于2024年3月4日出售3760股普通股，总市值为41,815美元。这些股票于2024年3月1日通过Arcutis Biotherapeutics的限制性股票背包收购。此次交易是在过去三个月中没有报告任何销售额的时期之后进行的。
Arcutis Biotherapeutics, Inc.高管松田正定于2024年3月4日出售3760股普通股，总市值为41,815美元。这些股票于2024年3月1日通过Arcutis Biotherapeutics的限制性股票背包收购。此次交易是在过去三个月中没有报告任何销售额的时期之后进行的。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息